Latest Pfizer Stories
In the next five years, emerging markets will continue to grow in importance for the industry, and large-cap pharmaceutical firms will seek to acquire or partner with biotechnology companies with promising drug candidates to bolster their thinning pipelines. For these reasons, industry research firm IBISWorld has updated a report on the Global Pharmaceuticals and Medicine Manufacturing industry to its growing report collection. Los Angeles, CA (PRWEB) June 04, 2013 Over the five years to...
TORONTO, June 4, 2013 /PRNewswire/ - Bontan Corporation Inc. ('the Company") (OTCBB: BNTNF) ("Bontan") is pleased to announce the official signing and completion of a share exchange agreement with all the shareholders of Portage Pharma Limited ("PPL"), a private Biotech corporation formed under the laws of the British Virgin Islands. Under the terms of the agreement, all the shares of PPL have been exchanged for approximately 81.7 million common shares of Bontan and approximately...
NES-ZIONA, Israel, June 4, 2013 /PRNewswire/ -- PROLOR Biotech, Inc. (NYSE Mkt: PBTH), a company developing next-generation biobetter therapeutic proteins, today announced the initiation of a pivotal Phase III clinical trial of hGH-CTP, the company's proprietary version of human growth hormone (hGH), in growth hormone deficient adults. PROLOR is developing hGH-CTP to provide growth hormone deficient adults and children with hGH therapy that may require only once-weekly or bi-monthly...
The firm is currently offering Lipitor lawsuit evaluations to women who have allegedly suffered from serious Lipitor side effects. Philadelphia, Penn. (PRWEB) May 29, 2013 Grocery chain Wegmans, looking to gain market share, is giving out free generic Lipitor to customers to whom the drug has been prescribed by doctors, according to the Philadelphia Inquirer.* The Rottenstein Law Group LLP, which manages the Lipitor Lawsuit Center at http://www.lipitorlawyer.us, is concerned by this...
BALTIMORE, May 29, 2013 /PRNewswire/ -- UPM Pharmaceuticals, a Baltimore, Maryland-based drug development and contract manufacturer, announced today that they will be acquiring the 500,000 square-foot commercial manufacturing facility that Pfizer Inc. (PFE) currently operates in Bristol, TN. The acquisition of the Pfizer facility will provide UPM with large scale commercial capabilities for manufacturing and packaging of solid oral dosage tablets and capsules, as well as...
Although Rheumatologists Indicate There is an Unmet Need for New RA Drug Therapies, Most Patients Do Not Want to Switch from Their Current Medication, According to a New Report from BioTrends Research Group EXTON, Penn., May 29, 2013 /PRNewswire/ -- BioTrends Research Group, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that rheumatoid arthritis patients are moderately to highly satisfied with the drugs, biologic and...
“CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - US” is the new market research report added to ReportsnReports.com store. Dallas, TX (PRWEB) May 28, 2013 The expansion of the insured population, prompted by the introduction of Patient Protection and Affordable Care Act (PPACA), will play a key role in driving US pharmaceutical market revenue up by a third by the end of the decade. The latest report on the US healthcare industry “CountryFocus: Healthcare,...
Treatment with ipilimumab can result in durable antitumor effects despite a low overall response rate in patients with advanced mucosal melanoma (MM). Richard D. Carvajal, MD, Medical Oncologist at the Memorial Sloan-Kettering Cancer Center in New York, led the multicenter, retrospective study, recently published in The Oncologist, in collaboration with researchers from the Dana-Farber Cancer Institute and Massachusetts General Hospital in Boston. Durham, NC (PRWEB) May 28, 2013 Treatment...
Improved Safety and Tolerability Compared with Current Therapies is Another Key Market Access Lever for Emerging Neuropathic Pain Therapies, According to a New Report from Decision Resources BURLINGTON, Mass., May 28, 2013 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that expanded labeling for additional neuropathic pain (NP) populations and/or broader NP labeling (peripheral NP) will not...
HONG KONG, May 28, 2013 /PRNewswire/ -- Insiderslab.com is has released insider trading report for investors who invest in stocks of US: Procter & Gamble (NYSE:PG), Pfizer (NYSE:PFE), Valeant Pharmaceuticals (NYSE:VRX), Bank of America (NYSE:BAC), Exxon Mobil (NYSE:XOM), and Marvell (NASDAQ:MRVL). (Logo: http://photos.prnewswire.com/prnh/20100419/HKM001LOGO ) (Read full report by clicking the link below, you may need to copy and paste the full link to your browser.) Report...
Latest Pfizer Reference Libraries
Clostridium difficile, also known as "CDF/cdf", or "C. diff", is a Gram-positive bacteria of the genus Clostridium that causes severe diarrhea and other intestinal disease when competing bacteria in the gut flora are wiped out by antibiotics. They are anaerobic, spore-forming rods and is the most serious cause of antibiotic-associated diarrhea and potentially to pseudomembranous colitis. C. difficile bacteria naturally resides in the gut of a small percentage of the adult population. Others...
